WHITEHAWK THERAPEUTICS, INC. Preferred Stock, Par or Stated Value Per Share
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Preferred Stock, Par or Stated Value Per Share of $0.00 per share as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2026-08-06
- 2026-06-30: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2026-03-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.00.
- 2025-09-30: Preferred Stock, Par or Stated Value Per Share $0.00.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-13 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-11 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 |
| 2020-12-31 | $0.00 10-Q · filed 2021-08-11 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-13 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-10 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 |
| 2017-03-10 | $0.00 10-K · filed 2019-03-07 |
| 2017-03-09 | $0.00 10-Q · filed 2019-11-07 |
| 2017-03-03 | $0.00 10-K · filed 2019-03-07 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-07 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-07 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-13 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-13 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-28 |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |